N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide details of its work plan following
With its shares rising sharply against a falling market, shareholders of Russian Nickel play Amur Minerals (AMC) have been able to hold their head high against a falling market.
Zak Mir takes a charting perspective to some of the most followed small caps on the London stock market. Today’s selection includes Catenae, Kodal, Kromek, N4 Pharma, Polarean, Poolbeg, Pires,
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a strategic update following data from
Zak Mir takes a technical perspective on some of the most followed stocks on the London market. Today’s selection includes AfriTin Mining, Beowulf Mining, Bigblu Broadband, Chesterfield Resources, Genedrive, Jubilee
The FTSE 100 was heavily affected by uncertainty on the first trading day. The UK blue-chip index fell 59 points (0.84%) by Friday’s close to maintain its level of 7,027.
Zak Mir takes a technical analysis perspective on some of the most followed small caps on the London market. Today’s selection includes Cellular Goods, Caracal, Europa, Empire Metals, N4 Pharma,
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines.
Turning to the wider small-cap market, the AIM All-Share was down 1.2% over the week, which meant it underperformed the FTSE 100, which more or less kept its head above
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a further update on its current
N4 Pharma plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an update on its current work
